Progress in Antibody-Guided Vaccine Design for Viruses
A special issue of Biologics (ISSN 2673-8449). This special issue belongs to the section "Vaccines".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 305
Special Issue Editor
2. School of Human Sciences, London Metropolitan University, Holloway Road, London N7 8DB, UK
Interests: viruses; vaccines; monoclonal antibodies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advances in vaccines for viruses are influenced by knowledge regarding immune responses to natural infection. For this Special Issue, we are interested in studies that use antibody responses to viruses to guide novel vaccine design. Studies may include polyclonal responses in model systems, monoclonal antibody-directed epitope identification, structural biology information of antibody-antigen interaction, synthetic antibody screening and reverse engineering of vaccines, traditional immunization approaches and monoclonal antibody discovery, or AI-assisted antibody engineering and bioinformatic analyses. The common theme must be the use of antibodies to guide viral vaccine design.
For this Special Issue, we are interested in receiving high-quality reviews or research articles describing the development of new vaccines for viruses that have been influenced by the detailed knowledge of antibody responses. Studies can be focused on any virus or animal humoral immune response or antibody synthetic platform. Accepted papers will be thoroughly peer-reviewed and must describe innovative research studies contributing to the field or be authoritative reviews of the subject. There must be a component of antibody-directed vaccine design.
Prof. Dr. Gary McLean
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biologics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral infections
- antibodies
- polyclonal
- monoclonal
- synthetic
- vaccine design
- epitopes
- structural biology
- immunization
- bioinformatics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
